Evidence map›Paper›PMID 31571990›Full record

ArticleCancer management and research2019

Spatial heterogeneity of

Anthony Turpin, Michael Genin, Mohamed Hebbar, Florent Occelli, Caroline Lanier, Francis Vasseur, Clotilde Descarpentries, Diane Pannier, Anne Ploquin

Abstract read
In one paragraph

Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2023
    Article
  4. Malfeasance of KRAS mutations in carcinogenesis.Clinical and experimental medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anthony TurpinMedical oncology unit, Hôpital Claude Huriez, F-59000 Lille, France.
Michael GeninEA 2694-Santé Publique: épidémiologie et qualité des soins, University Lille, CHU Lille, 59000 Lille, France.
Mohamed HebbarMedical oncology unit, Hôpital Claude Huriez, F-59000 Lille, France.
Florent OccelliEA 4483 - Impact de l'environnement chimique sur la santé humaine, University of Lille, 59000 Lille, France.
Caroline LanierEA 4483 - Impact de l'environnement chimique sur la santé humaine, University of Lille, 59000 Lille, France.
Francis VasseurEA 2694-Santé Publique: épidémiologie et qualité des soins, University Lille, CHU Lille, 59000 Lille, France.
Clotilde DescarpentriesDivision of Biochemistry and Molecular Biology, Oncology and Molecular Genetics Laboratory, CHU Lille, Lille, France.
Diane PannierDepartment of Medical Oncology, Centre Oscar Lambret, Lille, F-59000, France.
Anne PloquinMedical oncology unit, Hôpital Claude Huriez, F-59000 Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSomatic mutations in the PURPOSE: In this study, we attempted to identify the potential geographical population clusters of PATIENTS AND

methodsAll patients with CRC who were identified to have

resultsA mutation at

conclusionThere was a spatial heterogeneity and a greater frequency of

Indexed as

carcinogenscolorectal cancerhighwaysKRAS mutationspatial scan statistics

Identifiers

PMID31571990
PMCPMC6750880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.